First National Bank of South Miami’s AbbVie ABBV Stock Holding History

First National Bank of South Miami’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$560K	Sell	4,154 -321	-7%	-$47.1K	0.45%	60
2023 Q1	$713K	Sell	4,475 -153	-3%	-$23.4K	0.57%	52
2022 Q4	$748K	Sell	4,628 -103	-2%	-$15.8K	0.56%	54
2022 Q3	$635K	Sell	4,731 -590	-11%	-$84.7K	0.49%	59
2022 Q2	$815K	Buy	5,321 +426	+9%	+$65.1K	0.56%	49
2022 Q1	$794K	Buy	4,895 +431	+10%	+$62.6K	0.48%	55
2021 Q4	$604K	Buy	4,464 +347	+8%	+$41K	0.37%	68
2021 Q3	$444K	Buy	4,117 +347	+9%	+$39.6K	0.3%	78
2021 Q2	$425K	Buy	3,770 +128	+4%	+$14.4K	0.29%	80
2021 Q1	$394K	Buy	3,642 +612	+20%	+$65.5K	0.3%	81
2020 Q4	$325K	Buy	3,030 +245	+9%	+$23.5K	0.28%	82
2020 Q3	$244K	Buy	2,785 +472	+20%	+$44.4K	0.23%	90
2020 Q2	$227K	Buy	2,313 +166	+8%	+$14.6K	0.25%	88
2020 Q1	$164K	Sell	2,147 -29	-1%	-$2.47K	0.21%	97
2019 Q4	$193K	Sell	2,176 -193	-8%	-$16K	0.19%	107
2019 Q3	$156K	Hold	2,369	–	–	0.15%	123
2019 Q2	$158K	Buy	2,369 +1,105	+87%	+$86.9K	0.15%	124
2019 Q1	$101K	Hold	1,264	–	–	0.1%	139
2018 Q4	$101K	Buy	+1,264	New	+$111K	0.1%	145

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First National Bank of South Miami's ABBV Position: Q2 2023 in Review

First National Bank of South Miami reduced its AbbVie (ABBV) stake by 7.2% in Q2 2023, selling an estimated $47.1K and leaving 4,154 shares worth $560K. The position accounts for 0.45% of the portfolio, ranked #60.

First National Bank of South Miami first reported a position in ABBV in Q4 2018 and has held it in 19 quarters since. The position peaked at $815K in Q2 2022. 3,079 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

First National Bank of South Miami held 4,154 shares of AbbVie worth $560K as of Q2 2023.
First National Bank of South Miami sold 321 AbbVie shares in Q2 2023, an estimated $47.1K.
AbbVie made up 0.45% of First National Bank of South Miami's portfolio in Q2 2023, its #60 holding.
First National Bank of South Miami first reported a position in AbbVie in Q4 2018 and has held it in 19 quarters since.
First National Bank of South Miami's AbbVie position peaked at $815K in Q2 2022.
3,079 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.